Table 3 The demographic, clinical, and laboratory data of the homozygous mutant, heterozygous, and wild genotype groups among the DR group
|  | (Homozygous wild AA) N = 20 (mean ± SD) | (Heterozygous AV) N = 47 (mean ± SD) | (Homozygous mutant VV) N = 33 (mean ± SD) | P value |
|---|---|---|---|---|
Age* | 57.8 ± 9.2 | 56.8 ± 9.2 | 60.1 ± 8.8 | 0.278 |
Sex | ||||
 Male n (%) | 8 (40%) | 21 (44.7%) | 17 (51.5%) | 0.695 |
 Female n (%) | 12 (60%) | 26 (55.3%) | 16 (48.5%) | |
DM duration* | 15.8 ± 7.1 | 18.4 ± 6.4 | 18.8 ± 7.1 | 0.254 |
Age of onset of diabetes* | 42 ± 11.3 | 38.43 ± 10.2 | 41.33 ± 10.4 | 0.320 |
Blood pressure state | ||||
 Hypertensive | 13 (65.0%) | 21 (44.7%) | 21 (63.6%) | 0.148 |
 Normotensive | 7 (35.0%) | 26 (55.3%) | 12 (36.4%) | |
Treatment | ||||
 Insulin n (%) oral | 16 (80.0%) | 39 (83.0%) | 22 (66.7%) | 0.219 |
Hypoglycemic n (%) | 4 (20.0%) | 8 (17.0%) | 11 (33.3%) | |
HbA1c (%)* | 8.1 ± 1 | 8.8 ± 1.7 | 8.9 ± 1.7 | 0.199 |
+ ve family history of DR | 4 (14.8%) | 16 (59.3%) | 7 (25.9%) | 0.326 |
History of argon laser | 16 (21.9%) | 37 (50.7%) | 20 (27.4%) | 0.146 |
History of vitrectomy | 6 (18.8%) | 17 (53.1%) | 9 (28.1%) | 0.687 |